+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

World Infectious Immunology Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3773005
  • Report
  • September 2019
  • Region: Global
  • Allied Analytics LLP
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now
Infection involves an attack of disease-causing agents such as bacteria and viruses on the host organism’s body that causes disturbances in normal functioning. Immunology is the study of the human body’s resistance to these infections. The combined study of infections and immunology would help authorities to handle infectious disease conditions including HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. The infectious immunology market comprises of the diagnosis and treatment of these infectious diseases with the help of antigen antibody reactions.

The infectious immunology market is segmented based on types of diseases into HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. Approximately 4,00,000 deaths are estimated to be caused by rotavirus infection. HBV affected nearly 1.4 million in the U.S. in 2011. The rising incidence of these infectious diseases creates a worldwide demand for immunological diagnostics and treatment. This suggests that the market would experience a growth spurt in the near future. However, the lack of technological developments and high cost associated with treatment would adversely affect market growth. The infectious immunology market is segmented based on the types of products used for treatment such as diagnostic kits, instruments and reagents. Diagnostic kits hold the dominant share due to their effectiveness. Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientifics, Bio-Rad Laboratories and Dr. Reddy’s Laboratories are the key players in the infectious immunology market.

Key benefits

In-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans
Comprehensive analysis of the factors that drive and restrict the growth of the infectious immunology market is provided
Key regulatory guidelines in various regions which impact the infectious immunology market are critically examined
Quantitative analysis of the current market and estimations through 2013-2020 are provided to showcase the financial calibre of the infectious immunology market
Deep dive analysis of various regions provides insights that would enable companies to plan their business moves strategically
Value chain analysis in the report gives a clear understanding of the roles of the stakeholders involved in the supply chain of the infectious immunology market

Market Segmentation

The infectious immunology market is segmented based on its application, product types and geography.

By Application

HIV

TB

HBV & HCV

Pneumonia

Malaria

Inflammatory Bowel Diseases

Auto Immune Diseases

Others

By Product Type

Diagnostic Kits

Instruments

Reagents

By Geography

North America

Asia Pacific

Europe

LAMEA

Note: Product cover images may vary from those shown
2 of 2

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll